secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2025-08-28T23:59:59+00:00
Accession:  0000950170-25-111974
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Iterum Therapeutics receives Nasdaq delisting notice for bid price below $1.00
------------------------------------------------------------------------------

- Nasdaq notice for non-compliance with minimum bid price rule; shares traded below $1.00 for 30 consecutive business days.
- 180-day cure period expires February 23, 2026; must close at $1.00 for 10 consecutive business days to regain compliance.
- May qualify for an additional 180-day period if it meets other listing standards and intends to cure via reverse split.
- Failure to cure could lead to delisting; company will monitor options but no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000095017025111974/0000950170-25-111974-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000095017025111974/itrm-20250825.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-111974

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer